Fluid Day Spanish Observational Study

NCT03630744 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3500

Last updated 2018-08-15

No results posted yet for this study

Summary

Perioperative fluid therapy has undergone a huge change in clinical practice in recent years. The patterns of replacement and / or restoration of volemia described in the classic anaesthesiology books were supported by weak scientific evidence, and a paradigm shift in perioperative fluid therapy based on aspects such as increased mortality associated with an excessively positive balance of fluids in the perioperative period, evidences related to the non-existence of the third non-anatomical space and the need to preserve the capillary endothelium and its glycocalyx.

On the other hand, advances in technology, through the availability of less invasive monitoring systems, capable of determining dynamic parameters related to blood volume that allow predicting the response to volume management, have provided much more adequate monitoring and simple to guide such intravenous volume restoration.

Following all these changes different guidelines and recommendations have been published in recent years with the intention of clarifying the current evidence and facilitate the correct use of fluid therapy to clinicians, but despite this the fact is that today the investigators still do not have information on how fluid therapy is administered in daily practice, so the section of Hemostasis, Transfusion Medicine and Fluid Therapy of SEDAR, considered it necessary to evaluate the clinical practice of fluid therapy in the perioperative period through the Fluidday study.

Conditions

  • Fluid Therapy

Interventions

OTHER

Fluid therapy

* Analyze the type of fluid administered: * crystalloids: * Saline serum 0.9% ....... ml * Ringer Lactate ........ ml * Isofundin ® ........ ml * Plasmalyte® ... ... ml * Glucose Serum 5% ....... ml * Glucose serum 10% ........ ml * Glucosaline serum ........ ml * colloids: * Hydroxyethyl starch 130 / 0.4 ... ... ml * Hydroxyethyl alimdon 130 / 0.42 ... .... ml * Gelatins ... ....... ml * Albumin 5% .......... ml * Albumin 20% .......... ml. * Analyze the total amount of crystalloids and liquid colloids administered in 24 hours in milliliters. * Analyze the form of administration: * Standard * Standard with dosimeters * on pump

Sponsors & Collaborators

  • Hospital Vall d'Hebron

    collaborator OTHER
  • Hospital Universitario Infanta Leonor

    collaborator OTHER
  • Hospital Verge dels Lliris

    collaborator UNKNOWN
  • Hospital Clinic of Barcelona

    collaborator OTHER
  • Hospital Universitario Doctor Peset

    collaborator OTHER
  • Hospital Miguel Servet

    collaborator OTHER
  • Hospital Universitario La Fe

    collaborator OTHER
  • Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-28
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03630744 on ClinicalTrials.gov